The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•7 May 2026•

1 min read

Healthcare and Real Estate Firms Beat Q1 Earnings Estimates Despite Net Losses

Key Facts

1Rapport Therapeutics reported a Q1 loss of $0.42 per share, beating the Zacks Consensus Estimate of a $0.56 loss.

2Aclaris Therapeutics reported a Q1 loss of $0.15 per share, beating the consensus estimate of a $0.16 loss and exceeding revenue estimates.

3The Real Brokerage reported a Q1 loss of $0.02 per share, beating the Zacks Consensus Estimate of a $0.03 loss.

Several small and mid-cap companies in the healthcare and real estate brokerage sectors reported Q1 financial results that exceeded analyst expectations. Rapport Therapeutics posted a loss of $0.42 per share, performing better than the $0.56 loss projected by the Zacks Consensus Estimate. Similarly, Aclaris Therapeutics reported a loss of $0.15 per share, beating the $0.16 consensus estimate and exceeding revenue targets. The Real Brokerage also outperformed expectations, reporting a loss of $0.02 per share compared to the anticipated $0.03. These narrower-than-expected losses suggest improved operational efficiency across these emerging firms. While these companies remain in a net loss position, the positive earnings surprises may provide a short-term boost to investor confidence.